Those pieces of evidence would indicate that the tumor cell response to LPA is a complex issue since it can vary depending on several factors, including the cancer cell type stimulated, the tumor stage, the LPA receptor expressed and the LPA species. The gene discussed is LPA; the disease is neoplasm.